Ilacirnon sodiumProduct ingredient for Ilacirnon

Show full entry for Ilacirnon
Name
Ilacirnon sodium
Drug Entry
Ilacirnon

Ilacirnon (CCX-140) is under investigation in clinical trial NCT01440257 (A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria).

See full entry for Ilacirnon
Accession Number
DBSALT003338
Structure
Synonyms
4-Chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidin-4-ylcarbonyl)-3-pyridinyl]-3-(trifluoromethyl)benzenesulfonamide, sodium salt / CCX-140 sodium
UNII
X39CM70JTQ
CAS Number
1100319-36-5
Not Available
Predicted Properties
Not Available